Yvan Caspar

854 total citations
44 papers, 525 citations indexed

About

Yvan Caspar is a scholar working on Molecular Biology, Genetics and Clinical Biochemistry. According to data from OpenAlex, Yvan Caspar has authored 44 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 13 papers in Genetics and 12 papers in Clinical Biochemistry. Recurrent topics in Yvan Caspar's work include Bacillus and Francisella bacterial research (19 papers), Bacterial Identification and Susceptibility Testing (12 papers) and Bacteriophages and microbial interactions (9 papers). Yvan Caspar is often cited by papers focused on Bacillus and Francisella bacterial research (19 papers), Bacterial Identification and Susceptibility Testing (12 papers) and Bacteriophages and microbial interactions (9 papers). Yvan Caspar collaborates with scholars based in France, Germany and Denmark. Yvan Caspar's co-authors include Max Maurin, Sandrine Boisset, Aurélie Hennebique, Danièle Maubon, Patricia Pavèse, Marie‐Reine Mallaret, Caroline Landelle, Isabelle Pelloux, Thomas Girard and Cécile Garnaud and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology.

In The Last Decade

Yvan Caspar

35 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yvan Caspar France 15 248 167 123 117 114 44 525
Kjersti Wik Larssen Norway 11 168 0.7× 63 0.4× 123 1.0× 63 0.5× 230 2.0× 16 358
Dietmar Grothues Germany 14 580 2.3× 152 0.9× 39 0.3× 84 0.7× 83 0.7× 19 947
Annelies De Bel Belgium 14 88 0.4× 34 0.2× 214 1.7× 286 2.4× 307 2.7× 31 615
Michela Corrò Italy 13 104 0.4× 62 0.4× 51 0.4× 42 0.4× 100 0.9× 34 316
David B. Needle United States 11 136 0.5× 83 0.5× 24 0.2× 90 0.8× 153 1.3× 35 344
Guadalupe Cortés Spain 9 151 0.6× 53 0.3× 40 0.3× 174 1.5× 127 1.1× 10 646
Kellie Burnside United States 14 250 1.0× 104 0.6× 41 0.3× 248 2.1× 217 1.9× 17 721
Ellen H. Fiss United States 11 167 0.7× 114 0.7× 29 0.2× 285 2.4× 242 2.1× 16 570
S. Hunt Gerardo United States 13 82 0.3× 41 0.2× 89 0.7× 88 0.8× 107 0.9× 23 457
Yoon K. Miller United States 9 184 0.7× 91 0.5× 12 0.1× 270 2.3× 81 0.7× 10 614

Countries citing papers authored by Yvan Caspar

Since Specialization
Citations

This map shows the geographic impact of Yvan Caspar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yvan Caspar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yvan Caspar more than expected).

Fields of papers citing papers by Yvan Caspar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yvan Caspar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yvan Caspar. The network helps show where Yvan Caspar may publish in the future.

Co-authorship network of co-authors of Yvan Caspar

This figure shows the co-authorship network connecting the top 25 collaborators of Yvan Caspar. A scholar is included among the top collaborators of Yvan Caspar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yvan Caspar. Yvan Caspar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rusniok, Christophe, Mylène Robert‐Genthon, Éric Faudry, et al.. (2025). Avirulent Pseudomonas aeruginosa T3SS-negative strains belonging to Clade 5 produce variable quantities of secondary metabolites. PubMed. 6. uqaf019–uqaf019.
3.
Moser, Poliana, Renaud Zelli, Yvan Caspar, et al.. (2025). Fast Release of Carboxylic Acid inside Cells. ChemMedChem. 20(9). e202500056–e202500056.
4.
Amara, Marlène, Laurent Dortet, Yvan Caspar, et al.. (2025). Bacterial epidemiology and antibiotic resistance rates in male urinary tract infections in France, 2019–2023. Infectious Diseases Now. 55(7). 105123–105123. 1 indexed citations
7.
Maurin, Max, et al.. (2024). Tularemia in Pediatric Patients: A Case Series and Review of the Literature. The Pediatric Infectious Disease Journal. 44(2). 180–185. 1 indexed citations
8.
Talarmin, Jean‐Philippe, et al.. (2024). Two cases of Francisella tularensis subspecies holartica prosthetic valve endocarditis, and review of the literature. European Journal of Clinical Microbiology & Infectious Diseases. 43(11). 2221–2225.
9.
Caspar, Yvan, Marion Le Maréchal, Stéphanie Lejeune, et al.. (2024). Clinical impact and cost-consequence analysis of ePlex® blood culture identification panels for the rapid diagnosis of bloodstream infections: a single-center randomized controlled trial. European Journal of Clinical Microbiology & Infectious Diseases. 43(6). 1193–1203. 4 indexed citations
10.
Guimard, Thomas, Estibaliz Lazaro, Olivia Peuchant, et al.. (2023). Case Studies and Literature Review of Francisella tularensis–Related Prosthetic Joint Infection. Emerging infectious diseases. 29(6). 1118–1126. 5 indexed citations
12.
Wackenheim, C., et al.. (2022). Dalbavancin in clinical practice: a particular place for the elderly?. European Journal of Clinical Microbiology & Infectious Diseases. 41(6). 977–979. 4 indexed citations
13.
Fraikin, Nathan, et al.. (2020). Bacterial behavior in human blood reveals complement evaders with some persister-like features. PLoS Pathogens. 16(12). e1008893–e1008893. 23 indexed citations
14.
Pierre, Isabelle, Danièle Maubon, Muriel Cornet, et al.. (2020). Evaluation of Microbiological Performance and the Potential Clinical Impact of the ePlex® Blood Culture Identification Panels for the Rapid Diagnosis of Bacteremia and Fungemia. Frontiers in Cellular and Infection Microbiology. 10. 594951–594951. 27 indexed citations
15.
Caspar, Yvan, et al.. (2018). Phenotypic and genetic resistance traits of Pseudomonas aeruginosa strains infecting cystic fibrosis patients: A French cohort study. International Journal of Antimicrobial Agents. 52(3). 358–364. 9 indexed citations
16.
Caspar, Yvan, Mylène Maillet, Patricia Pavèse, et al.. (2017). mcr-1 Colistin Resistance in ESBL-Producing Klebsiella pneumoniae, France. Emerging infectious diseases. 23(5). 874–876. 20 indexed citations
17.
Caspar, Yvan & Max Maurin. (2017). Francisella tularensis Susceptibility to Antibiotics: A Comprehensive Review of the Data Obtained In vitro and in Animal Models. Frontiers in Cellular and Infection Microbiology. 7. 122–122. 50 indexed citations
18.
Barone‐Rochette, Gilles, Patricia Pavèse, B. Bertrand, et al.. (2017). Incidence and prevention of infective endocarditis and bacteraemia after transcatheter aortic valve implantation in a French university hospital: a retrospective study. Journal of Hospital Infection. 99(1). 94–97. 14 indexed citations
19.
Caspar, Yvan, et al.. (2014). A new dye uptake assay to test the activity of antibiotics against intracellular Francisella tularensis. Frontiers in Cellular and Infection Microbiology. 4. 36–36. 14 indexed citations
20.
Caspar, Yvan, C. Recule, P Pouzol, et al.. (2013). Psychrobacter arenosusBacteremia after Blood Transfusion, France. Emerging infectious diseases. 19(7). 1118–1120. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026